2022 annual financial data
Indivior Pharmaceuticals 2022 Operating margin
Indivior Pharmaceuticals 2022 operating margin with verified reported values.
Direct answer
Operating margin was -8.99%.
Operating income was -81,000,000 USD and net income was -44,000,000 USD.
Operating cash flow was -4,000,000 USD.
Get free Indivior Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 901,000,000 USD
- Operating income
- -81,000,000 USD
- Net income
- -44,000,000 USD
- Operating cash flow
- -4,000,000 USD